Background: Recently, advances in bronchoscopic techniques such as bronchial valves have been increasing in value for Chronic Obstructive Pulmonary Disease (COPD). Bronchial valve therapy has been proven to be useful for patients with lobar heterogeneous emphysema and complete fi ssure. In this study, we measured emphysema scores and fi ssure integrity in patients with emphysema, then classifi ed these based on computed tomography image patterns to examine which patients were candidates for bronchial valve therapy.
Introduction
According to WHO estimates, 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD). More than 3 million people died of COPD in 2005, which corresponds to 5% of all deaths globally. In 2002, COPD was the fi fth leading cause of death. Total deaths from COPD are projected to increase by more than 30% in the next 10 years unless urgent action is taken to reduce the underlying risk factors, especially tobacco use. Estimates show that by 2030, COPD will have become those with lobar heterogeneous emphysema and complete interlobar fi ssure might be considered for bronchial valve therapy 13) . According to Mineshita et al., after CT review and once the fi ssure of at least one of both lungs is near complete (> 80%), they functionally assess collateral fl ow using the Chartis system. Patients who have no collateral fl ow receive a bronchial valve 14) . Bronchial valve therapy has not yet been done in Japan, but it will be started soon. St. Marianna University School of Medicine and Gifu Prefecture General Medical Center are research institutions that will perform this therapy. This study is a pilot study to select patients for bronchial valve therapy using CT. In this study, using image analysis software, we evaluated the emphysema phenotype and measured the emphysema score and fi ssure integrity in patients with CT-detected emphysema, then classifi ed these based on the image patterns to examine what proportion of patients with CT-detected emphysema were indicated for bronchial valve therapy according to CT image criteria.
Materials and Methods

Subjects
From February 2013 to May 2014, we studied 40 consecutive patients with CT-detected emphysema (4 women and 36 men, mean age 74 ± 8 years). Inclusion criteria for this study included the following: (1) patients with emphysema confi rmed by CT, (2) patients currently with or without treatment for emphysema; (3) 20 years of age or older with obtained consent; and (4) before study inclusion, all patients received a full explanation of the study, orally and in writing. Patients then gave written informed consent after obtaining a thorough understanding of the study. Exclusion criteria included the following: (1) patients with other major pulmonary disease such as interstitial pneumonia, lung cancer, respiratory tract infection; (2) patients unable to hold their breath sufficiently; and (3) patients judged to be inappropriate by physicians. All patients provided written informed consent, and the study was approved by the institutional review board at St. Marianna University School of Medicine and Gifu Prefectural General Medical Center.
Clinical and Physiologic Evaluation
Data on age, sex, body mass index (BMI), smoking history, modifi ed medical research council (MMRC), COPD assessment test (CAT), St. George's the third leading cause of death worldwide 1) . In addition, the PLATINO and BOLD studies have reported that the prevalence of COPD is about 10% worldwide 2)3)
. In 2010, the number of deaths from COPD in Japan was 16,293, making COPD the ninth leading cause of death, and the number of deaths is increasing 4) . A large-scale epidemiological study (Nippon COPD epidemiology study [NICE] ) estimated the prevalence of COPD in Japanese patients older than 40 years at 8.6%, and the number of patients at 5.3 million 5) . CT is reportedly effective in detecting COPD and lung cancer, and a meta-analysis of 7,368 patients reported that 2,809 and 870 had CT evidence of emphysema and lung cancer, respectively, and that CT-detected emphysema was an independent risk factor for lung cancer 6) . COPD is a type of obstructive lung disease in which chronic, incompletely reversible poor airfl ow (airfl ow limitation) and the inability to breathe out fully (air trapping) occur 7) . The poor airfl ow is the result of a breakdown of lung tissue (known as emphysema) and small airway disease (known as obstructive bronchiolitis).
Today, advances in bronchoscopic techniques such as bronchial valves have been increasing the value of CT quantitative analysis for COPD patients. Apollo software (VIDA Diagnostics, Inc.) is a quantitative lung imaging software which uses algorithmic workfl ow and automation features applicable to high-volume, repeatable parenchymal, airway, and fi ssure integrity analysis [8] [9] [10] . In the Endobronchial Valve for Emphysema Palliation Trial (VENT study), unilateral lobar treatment with bronchial valves resulted in modest improvements in lung function, exercise tolerance, and symptoms in patients with advanced heterogeneous emphysema 11) . However, the presence of collateral ventilation (CV) could undermine the effectiveness of valve treatment. According to Gompelmann's report, when evaluating patients for the likelihood of successful bronchial valve therapy, the Chartis system CV assessment and high-resolution computerized tomography (HRCT) fissure analysis appear to have comparable accuracy 12) . Shah et al. proposed an algorithm for bronchoscopic lung volume reduction (BLVR) in patients with severe emphysema based on CT image analysis and stated that determination of the emphysema phenotype from the CT scan was important, because patients with predominantly paraseptal emphysema or with small airway disease were unlikely to respond. Furthermore, they stated that respiratory questionnaire for COPD patients (SGRQ-C), exacerbation history, and receiving continuous oxygen were collected by patient interview using standardized instruments. Health status was assessed using CAT and the SGRQ-C. Dyspnea was assessed using MMRC. Patients underwent postbronchodilator spirometry, diffuse capacity of the lung for carbon monoxide (DLco), and 6-minute walk test (6MWT). The protocol used for 6MWT had been described in detail elsewhere 15) .
CT and Quantitative Analysis
All subjects were scanned with 64-detector CT (Aquilion-64; Toshiba Medical Systems, Tochigi, Japan) at full inspiration and full expiration (endexpiration), without receiving contrast medium. Every patient was carefully instructed on how to breathe before the study. Tube voltage was 120 kV, and tube current varied depending on the subject's BMI (100 to 190 mA). CT images were reconstructed with 1.0 mm slice thickness at 0.5 mm intervals, using a normal mode reconstruction algorithm (kernel, FC 01).
Emphysema phenotype was visually assessed by three radiologists.
Quantitative image analysis was performed using Apollo software (VIDA Diagnostics Pulmonary Workstation Plus Software, Iowa City, Iowa, USA). The emphysema score was defi ned as % lung voxels less than or equal to −910 Hounsfi eld units (HU) on inspiratory CT. The emphysema score per lobe was converted to a Likert scale, with a score of 1 = 1 to 25%, 2 = 26 to 50%, 3 = 51 to 75%, and 4 = 76 to 100%. Lobar homogeneous emphysema was defi ned as fewer than 2-unit differences between adjacent lobes 16) . And lobar heterogeneous emphysema was defi ned as more than or equal to 2-unit differences between adjacent lobes 11) . Fissure integrity was assessed using VIDA software. This system is more accurate than simply visually determining the integrity of the fissure. Fissure integrity scores of 80% and < 80% were defi ned as complete and incomplete fi ssure integrity, respectively 14) . First, CT emphysema was classifi ed into a heterogeneous emphysema group and a homogeneous emphysema group by emphysema scores. Second, the heterogeneous emphysema group and the homogeneous emphysema group were classifi ed into a complete fi ssure group and an incomplete fi ssure group by fi ssure integrity scores.
Results
The patients' characteristics are listed in Table 1 .
Patient characteristics (n=40)
Mean ±SD or n (%) were detected. For emphysema type, thirty-nine patients had centrilobular emphysema, and one patient had paraseptal emphysema. An example of the quantitative analysis and qualitative assessment of emphysema is shown in Figure 1 . First, the emphysema score per lobe was converted to a Likert scale; we classifi ed patients into a heterogeneous group and a homogeneous group using 2 unit differences between adjacent lobes (Fig.  1) . Second, the heterogeneous group and homogeneous group were divided into a complete and an incomplete fi ssure group by fi ssure integrity scores of 80% (Fig. 2) . Finally, 40 patients were classifi ed into a heterogeneous group of 5 patients, and a homogeneous group of 35 patients. The heterogeneous group was then further classifi ed into a complete fi ssure The colored regions represent connected regions of the lung voxels below -910 HU. Each color represents a different lobe. The patient on the left belongs to the homogeneous emphysema group whose computed tomography (CT) scores have fewer than 2-unit differences between adjacent lobes. The patient on the right belongs to the heterogeneous emphysema group whose CT scores have more than or equal to 2-unit differences between adjacent lobes. In the patient on the right, the emphysema score of 63.8% for the left upper lobe is converted to a CT score of 3 on the Likert scale, and the emphysema score of 24.0% of the left lower lobe is converted to a CT score of 1.
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging 17) , 40 patients were classifi ed as follows: healthy smokers = 5; GOLD stage I = 10 patients; stage II = 19 patients; stage III = 2 patients; and stage IV = 4 patients (mean forced expiratory volume [FEV] in 1 second of predicted, 71 ± 23%; FEV 1 range, 31 to 134%).
No large emphysema bulla and bronchiectasis group of 2 patients and an incomplete fi ssure group of 3 patients. The homogeneous group was classifi ed into a complete fi ssure group of 14 patients and an incomplete fi ssure group of 21 patients. As a result, the 2 patients with heterogeneous emphysema and complete fi ssure were candidates for bronchial valve therapy according to the criteria for CT images (Fig.  3) .
Discussion
In recent years, BLVR with valve has emerged as a new therapeutic option for severe emphysema. As we consider this therapy, it is also important to consider emphysema phenotype, heterogeneity, and fi ssure integrity from CT scans. In particular, patients with heterogeneous emphysema and complete fi ssure maybe considered for this therapy 12)13)14)
. Venuta et al. reported on the long-term follow-up after BLVR with valve in patients with emphysema. They reported that survival rates at 1, 3, and 5 years were 81.6%, 47.4%, and 22.4%, respectively. They also noted an increase in mortality during the follow-up period in patients with nonvisible fi ssures at HRCT 18) . In this study, we focused on emphysema phenotype, heterogeneity, and fi ssure integrity.
The highest frequency of emphysema phenotype was centrilobular pattern, and the homogeneous group was larger in number than the heterogeneous group. There were two patients with heterogeneous emphysema and complete fi ssure, and they were indicated for bronchial valve therapy according to CT images.
Gietema et al. reported that the highest frequency of emphysema phenotype was centrilobular pattern, and the highest frequency of emphysema distribution was the upper lobe in the visual score assigned by the radiologist. They also reported that the percentage of low attenuation area (%LAA) and visual scores of emphysema severity correlated well and that computer analysis of low attenuation cluster size helped quantitative algorithms discriminate low attenuation areas from gas trapping, image noise, and emphysema 10) . Stavngaard et al. introduced a CTbased objective model for describing the distribution of different types of emphysema. Their methods were as follows: The relative area of emphysema in each CT slice was plotted against table position, and the cranio-caudal distribution was calculated as the slope of the regression line. They reported that the majority of patients with smoking-related emphysema had a homogeneous distribution and lower lobe predominance, although not as noticeable as in a 1 -antitrypsin deficiency 19) . In this study, the majority of patients with CT-detected emphysema had centrilobular pattern and homogeneous emphysema. However, there were no cases with emphysema of lower lobe predominance in the heterogeneous group.
Fissure integrity is important in considering the bronchial valve treatment. Jiantao et al. reported that there was no signifi cant difference in fi ssure integrity for patients with different levels of disease severity, suggesting that the development of COPD does not change the completeness of pulmonary fi ssures, and that incomplete fi ssures alone may not contribute to the collateral ventilation 20) . It can be said that COPD has not only a single pathology, but also a variety of pathological conditions.
To our knowledge, this is the fi rst study that describes the classifi cation by lobar heterogeneity and fi ssure integrity using Apollo software in Japan. The number of patients in the heterogeneous group in this study was too small to clarify the adaptation of bronchial valve therapy. Some severe COPD patients did not agree to this study because of dyspnea. Therefore, further analysis of a heterogeneous patient group is needed.
Since bronchial valve therapy is not performed in Japan, there is no data indicating the validity of this study. If this therapy is started, it will be necessary to evaluate the method of patient selection.
In this study, fi ssure integrity was evaluated using VIDA Apollo software since visual evaluation of fi ssure may not be reliable 21) . VIDA Apollo software is a semi-automated software that evaluates the integrity of the fissure on a thin slice CT scan. This software may be more accurate than attempting to visually determine the integrity of the fissure 13) . The assessment of fi ssure integrity has been developed, but its widespread use poses a problem in that data requires specialist analysis. Furthermore, the completeness of the fi ssure as determined by the software and its accuracy in predicting volume reduction has not been prospectively validated. Regarding its accuracy and relationship with collateral airfl ow, a comparative study with the Chartis system is necessary. Herth et al. noted that the Chartis system was a safe method to predict lung volume reduction, with accuracy of 75% 22) . COPD is a diverse disease. When detailed analysis of CT images becomes possible, in order to consider appropriate intervention, it is necessary to perform prospective analysis of emphysema, heterogeneity, and fi ssure integrity, thereby elucidating the pathogenesis and progression of emphysema. In addition, since various methods for BLVR are currently available, it is necessary to establish a treatment algorithm for BLVR based on clinical and CT fi ndings. Furthermore, possible factors for the difference in the pathogenesis of emphysema among Japanese, Europeans, and Americans include external factors (such as air pollution) and internal factors (such as genetic predisposition). For example, 1-antitrypsin defi ciency, as a genetic predisposition, is well known in Europe and the United States, but is extremely rare in Japan 23) . Therefore, a treatment algorithm for BLVR in Japanese patients may be necessary.
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